13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001773206
Total reported value
$2.5B
$2.5B
84 檔
23.9%
As reported in its official Q4 2025 Form 13F filing, Integral Health Asset Management, LLC's tracked investment portfolio stood at $2.5B with 84 total positions.
In Q4 2025, Integral Health Asset Management, LLC displayed an active expansion posture, initiating 23 new positions and adding to 34 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | INSM | Insmed Inc | Stock-Healthcare | 10.80% | -4.99% | -26.47% | |
| 2 | CYTK | Cytokinetics Inc | Stock-Healthcare | 5.99% | -2.82% | -11.63% | |
| 3 | RVMD | Revolution Medicines Inc | Stock-Healthcare | 4.75% | +0.53% | +200.00% | |
| 4 | VERA | Vera Therapeutics Inc | Stock-Other | 4.53% | -0.11% | +5.88% | |
| 5 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 4.02% | -2.15% | +110.00% | |
| 6 | MDT | Medtronic plc | Stock-Healthcare | 3.22% | +0.62% | NEW | |
| 7 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 3.09% | -0.77% | EXIT | |
| 8 | RYTM | Rhythm Pharmaceuticals Inc | Stock-Other | 2.52% | -0.09% | +115.91% | |
| 9 | ALHC | Alignment Healthcare Inc | Stock-Other | 2.16% | -0.29% | +37.50% | |
| 10 | CAH | Cardinal Health Inc | Stock-Healthcare | 2.04% | +0.09% | +53.85% | |
| 11 | CVS | Cvs Health CORP | Stock-Healthcare | 1.97% | +3.97% | +150.00% | |
| 12 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 1.85% | +0.80% | — | |
| 13 | GKOS | Glaukos CORP | Stock-Healthcare | 1.82% | -0.07% | +225.00% | |
| 14 | MLYS | Mineralys Therapeutics Inc | Stock-Other | 1.80% | -1.14% | -33.33% | |
| 15 | NVS | Novartis Ag-sponsored Adr | Stock-Healthcare | 1.71% | -0.59% | +25.00% | |
| 16 | DXCM | Dexcom Inc | Stock-Healthcare | 1.65% | -0.53% | EXIT | |
| 17 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 1.60% | — | +16.67% | |
| 18 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 1.55% | — | — | |
| 19 | PEN | Penumbra Inc | Stock-Healthcare | 1.54% | — | +100.00% | |
| 20 | TFX | Teleflex Inc | Stock-Healthcare | 1.51% | — | — | |
| 21 | BTSG | Brightspring Health Services | Stock-Other | 1.39% | -1.03% | -34.78% | |
| 22 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 1.38% | +1.58% | +62.50% | |
| 23 | CNC | Centene CORP | Stock-Healthcare | 1.33% | -0.26% | +62.50% | |
| 24 | COO | Cooper Cos Inc/the | Stock-Healthcare | 1.32% | -0.51% | EXIT | |
| 25 | MRK | Merck & Co. Inc. | Stock-Healthcare | 1.31% | -0.66% | — | |
| 26 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 1.18% | — | — | |
| 27 | IRTC | Irhythm Holdings Inc | Stock-Healthcare | 1.15% | +0.42% | NEW | |
| 28 | QURE | uniQure N.V. | Stock-Other | 1.07% | +0.94% | +50.00% | |
| 29 | LLY | Eli Lilly & Co | Stock-Healthcare | 1.07% | +0.05% | — | |
| 30 | BSX | Boston Scientific CORP | Stock-Healthcare | 1.07% | -0.13% | -25.00% | |
| 31 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 1.06% | +0.05% | — | |
| 32 | LFST | Lifestance Health Group Inc | Stock-Other | 1.05% | -0.04% | +100.00% | |
| 33 | ELV | Elevance Health Inc | Stock-Healthcare | 1.04% | -0.29% | +20.00% | |
| 34 | UPB | Upstream Bio Inc | Stock-Other | 1.01% | — | +30.43% | |
| 35 | THC | Tenet Healthcare CORP | Stock-Healthcare | 0.99% | +1.22% | NEW | |
| 36 | ASND | Ascendis Pharma A/S | Stock-Other | 0.95% | -1.26% | EXIT | |
| 37 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 0.92% | +0.15% | +13.33% | |
| 38 | DOCS | Doximity Inc-class A | Stock-Healthcare | 0.88% | — | +122.22% | |
| 39 | BIIB | Biogen Inc | Stock-Healthcare | 0.87% | +0.32% | — | |
| 40 | RGNX | Regenxbio Inc | Stock-Other | 0.86% | -0.22% | +9.09% | |
| 41 | 430 | Terns Pharmaceuticals Inc | Stock-Other | 0.85% | — | -55.26% | |
| 42 | BHVN | Biohaven Ltd. | Stock-Other | 0.84% | +0.01% | +130.77% | |
| 43 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 0.82% | +1.40% | NEW | |
| 44 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 0.81% | -0.67% | EXIT | |
| 45 | FMS | Fresenius Medical Care-adr | Stock-Other | 0.77% | -0.84% | EXIT | |
| 46 | BEAM | Beam Therapeutics Inc | Stock-Other | 0.76% | +0.07% | +37.50% | |
| 47 | SLNOEUR | Soleno Therapeutics Inc | Stock-Other | 0.75% | -0.52% | EXIT | |
| 48 | RDNT | Radnet Inc | Stock-Healthcare | 0.71% | — | -33.33% | |
| 49 | SRRK | Scholar Rock Holding CORP | Stock-Other | 0.66% | +0.45% | +200.00% | |
| 50 | ACLXGBX | Arcellx Inc | Stock-Other | 0.65% | — | +33.33% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | RVMD | Revolution Medicines Inc | +3.5% | +200.00% | Add |
| 2 | ISRG | Intuitive Surgical Inc | +2.3% | +340.00% | Add |
| 3 | MDT | Medtronic plc | +2.3% | +350.00% | Add |
| 4 | REGN | Regeneron Pharmaceuticals | +2.1% | +110.00% | Add |
| 5 | GKOS | Glaukos CORP | +1.3% | +225.00% | Add |
| 6 | VERA | Vera Therapeutics Inc | +1.2% | +5.88% | Add |
| 7 | RYTM | Rhythm Pharmaceuticals Inc | +1% | +115.91% | Add |
| 8 | CVS | Cvs Health CORP | +1% | +150.00% | Add |
| 9 | COO | Cooper Cos Inc/the | +0.9% | +242.11% | Add |
| 10 | PEN | Penumbra Inc | +0.7% | +100.00% | Add |
| 11 | CAH | Cardinal Health Inc | +0.7% | +53.85% | Add |
| 12 | LFST | Lifestance Health Group Inc | +0.5% | +100.00% | Add |
| 13 | SRRK | Scholar Rock Holding CORP | +0.4% | +200.00% | Add |
| 14 | IRTC | Irhythm Holdings Inc | +0.4% | +100.00% | Add |
| 15 | 430 | Terns Pharmaceuticals Inc | +0.4% | -55.26% | Trim |
| 16 | CNC | Centene CORP | +0.4% | +62.50% | Add |
| 17 | EW | Edwards Lifesciences CORP | +0.3% | +62.50% | Add |
| 18 | UPB | Upstream Bio Inc | +0.3% | +30.43% | Add |
| 19 | ALHC | Alignment Healthcare Inc | +0.3% | +37.50% | Add |
| 20 | ANRO | Alto Neuroscience Inc | +0.2% | -6.25% | Trim |
| 21 | EWTX | Edgewise Therapeutics Inc | +0.2% | — | Unchanged |
| 22 | TARA | Protara Therapeutic Inc | +0.2% | +60.71% | Add |
| 23 | BHVN | Biohaven Ltd. | +0.2% | +130.77% | Add |
| 24 | DNTH | Dianthus Therapeutics Inc | +0.2% | +83.33% | Add |
| 25 | ROIV | Roivant Sciences Ltd. | +0.2% | +13.33% | Add |
| 26 | ASND | Ascendis Pharma A/S | +0.1% | +50.00% | Add |
| 27 | RGNX | Regenxbio Inc | +0.1% | +9.09% | Add |
| 28 | SANA | Sana Biotechnology Inc | +0.1% | +50.00% | Add |
| 29 | BEAM | Beam Therapeutics Inc | +0.1% | +37.50% | Add |
| 30 | NRIX | Nurix Therapeutics Inc | +0.1% | -14.29% | Trim |
| 31 | AZNN | Astrazeneca Plc-spons Adr | 0% | +16.67% | Add |
| 32 | LLY | Eli Lilly & Co | 0% | — | Unchanged |
| 33 | TENX | Tenax Therapeutics Inc | 0% | — | Unchanged |
| 34 | LBRX | Lb Pharmaceuticals Inc | — | — | Unchanged |
| 35 | DOCS | Doximity Inc-class A | 0% | +122.22% | Add |
| 36 | NVS | Novartis Ag-sponsored Adr | 0% | +25.00% | Add |
| 37 | FMS | Fresenius Medical Care-adr | 0% | +44.44% | Add |
| 38 | ELV | Elevance Health Inc | -0.1% | +20.00% | Add |
| 39 | APLSUSD | Apellis Pharmaceuticals Inc | -0.1% | -20.00% | Trim |
| 40 | ACLXGBX | Arcellx Inc | -0.2% | +33.33% | Add |
| 41 | ARWR | Arrowhead Pharmaceuticals In | -0.2% | -55.56% | Trim |
| 42 | CRL | Charles River Laboratories | -0.2% | -25.00% | Trim |
| 43 | TARS | Tarsus Pharmaceuticals Inc | -0.2% | -20.00% | Trim |
| 44 | NVST | Envista Holdings CORP | -0.2% | -9.09% | Trim |
| 45 | ORIC | Oric Pharmaceuticals Inc | -0.2% | +33.33% | Add |
| 46 | INSP | Inspire Medical Systems Inc | -0.3% | -37.50% | Trim |
| 47 | NBIX | Neurocrine Biosciences Inc | -0.4% | — | Unchanged |
| 48 | DGX | Quest Diagnostics Inc | -0.5% | -11.76% | Trim |
| 49 | OSCR | Oscar Health Inc - Class A | -0.6% | -63.64% | Trim |
| 50 | ALNY | Alnylam Pharmaceuticals Inc | -0.7% | — | Unchanged |
According to official SEC Form 13F filings, Integral Health Asset Management, LLC reported a total U.S. public equity portfolio value of $2.5B across 84 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including INSM, CYTK, RVMD) accounted for 23.9% of total reported equity market value during Q4 2025.
Top New Position Initiated
DXCM
市值: $33.2M
Top Position Liquidated / Trimmed
NAMS
前期市值: $28.4M
During Q4 2025, Integral Health Asset Management, LLC's top holdings by market value included INSM (10.8%)、CYTK (6.0%)、RVMD (4.8%). The largest single position, INSM, represented 10.8% of total portfolio value.
In Q4 2025, Integral Health Asset Management, LLC made 90 total portfolio adjustments, initiating 23 new buys, adding to 34 positions, trimming 20 holdings, and fully liquidating 13 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.